A phase I parallel, single-centre, double-blind, randomized, placebo-controlled, single-dose, two-period, two-treatment, two-sequence, crossover study of Lixisenatide in healthy subjects.

Trial Profile

A phase I parallel, single-centre, double-blind, randomized, placebo-controlled, single-dose, two-period, two-treatment, two-sequence, crossover study of Lixisenatide in healthy subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 31 May 2016

At a glance

  • Drugs Lixisenatide (Primary)
  • Indications Diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 31 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top